The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers.

Published on Jan 1, 2017in Cancer Epidemiology, Biomarkers & Prevention4.344
· DOI :10.1158/1055-9965.EPI-16-0106
Christopher I. Amos132
Estimated H-index: 132
(Dartmouth College),
Joe Dennis55
Estimated H-index: 55
(University of Cambridge)
+ 90 AuthorsDouglas F. Easton172
Estimated H-index: 172
(University of Cambridge)
Background:Common cancers develop through a multistep process often including inherited susceptibility. Collaboration among multiple institutions, and funding from multiple sources, has allowed the development of an inexpensive genotyping microarray, the OncoArray. The array includes a genome-wide backbone, comprising 230,000 SNPs tagging most common genetic variants, together with dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers and cancer related traits. Methods:The OncoArray can be genotyped using a novel technology developed by Illumina to facilitate efficient genotyping. The consortium developed standard approaches for selecting SNPs for study, for quality control of markers and for ancestry analysis. The array was genotyped at selected sites and with prespecified replicate samples to permit evaluation of genotyping accuracy among centers and by ethnic background. Results:The OncoArray consortium genotyped 447,705 samples. A total of 494,763 SNPs passed quality control steps with a sample success rate of 97% of the samples. Participating sites performed ancestry analysis using a common set of markers and a scoring algorithm based on principal components analysis. Conclusions:Results from these analyses will enable researchers to identify new susceptibility loci, perform fine mapping of new or known loci associated with either single or multiple cancers, assess the degree of overlap in cancer causation and pleiotropic effects of loci that have been identified for disease-specific risk, and jointly model genetic, environmental and lifestyle related exposures. Impact:Ongoing analyses will shed light on etiology and risk assessment for many types of cancer.
📖 Papers frequently viewed together
866 Citations
652 Citations
8,704 Citations
#1Yafang Li (Dartmouth College)H-Index: 14
#2Jinyoung Byun (Dartmouth College)H-Index: 14
Last. Christopher I. Amos (Dartmouth College)H-Index: 132
view all 12 authors...
Background Identifying subpopulations within a study and inferring intercontinental ancestry of the samples are important steps in genome wide association studies. Two software packages are widely used in analysis of substructure: Structure and Eigenstrat. Structure assigns each individual to a population by using a Bayesian method with multiple tuning parameters. It requires considerable computational time when dealing with thousands of samples and lacks the ability to create scores that could ...
31 CitationsSource
#1Madalene Earp (Mayo Clinic)H-Index: 10
#2Stacey J. Winham (Mayo Clinic)H-Index: 29
Last. Ellen L. Goode (Mayo Clinic)H-Index: 69
view all 54 authors...
Background Genome-wide association studies have identified several common susceptibility alleles for epithelial ovarian cancer (EOC). To further understand EOC susceptibility, we examined previously ungenotyped candidate variants, including uncommon variants and those residing within known susceptibility loci.
3 CitationsSource
#1Huong Meeks (UofU: University of Utah)H-Index: 8
#2Honglin Song (University of Cambridge)H-Index: 48
Last. David E. Goldgar (UofU: University of Utah)H-Index: 110
view all 253 authors...
Background: The K3326X variant in BRCA2 (BRCA2*c.9976A>T; p.Lys3326*; rs11571833) has been found to be associated with small increased risks of breast cancer. However, it is not clear to what extent linkage disequilibrium with fully pathogenic mutations might account for this association. There is scant information about the effect of K3326X in other hormone-related cancers. Methods: Using weighted logistic regression, we analyzed data from the large iCOGS study including 76 637 cancer case pati...
64 CitationsSource
#1Deborah J. Thompson (University of Cambridge)H-Index: 59
#2Tracy A. O'Mara (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 23
Last. Amanda B. Spurdle (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 86
view all 81 authors...
Candidate gene studies have reported CYP19A1 variants to be associated with endometrial cancer and with estradiol (E-2) concentrations. We analyzed 2937 single nucleotide polymorphisms (SNPs) in 6608 endometrial cancer cases and 37 925 controls and report the first genome wide-significant association between endometrial cancer and a CYP19A1 SNP (rs727479 in intron 2, P=4.8x10(-11)). SNP rs727479 was also among those most strongly associated with circulating E-2 concentrations in 2767 post-menopa...
37 CitationsSource
#1Lindsey A. Torre (ACS: American Cancer Society)H-Index: 16
#2Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 3 authors...
Lung cancer is the leading cause of cancer death among both men and women in the United States. It is also the leading cause of cancer death among men and the second leading cause of cancer death among women worldwide. Lung cancer rates and trends vary substantially by sex, age, race/ethnicity, socioeconomic status, and geography because of differences in historical smoking patterns. Lung cancer mortality rates in the United States are highest among males, blacks, people of lower socioeconomic s...
990 CitationsSource
#1Linda Kachuri (U of T: University of Toronto)H-Index: 13
#2Christopher I. Amos (Dartmouth College)H-Index: 132
Last. Rayjean J. Hung (U of T: University of Toronto)H-Index: 65
view all 44 authors...
Chromosome 5p15.33 has been identified as a lung cancer susceptibility locus, however the underlying causal mechanisms were not fully elucidated. Previous fine-mapping studies of this locus have relied on imputation or investigated a small number of known, common variants. This study represents a significant advance over previous research by investigating a large number of novel, rare variants, as well as their underlying mechanisms through telomere length. Variants for this fine-mapping study w...
26 CitationsSource
#1Yanhong Liu (BCM: Baylor College of Medicine)H-Index: 22
#2Farrah Kheradmand (BCM: Baylor College of Medicine)H-Index: 46
Last. Margaret R. Spitz (BCM: Baylor College of Medicine)H-Index: 114
view all 22 authors...
Abstract Introduction The association between smoking-induced chronic obstructive pulmonary disease (COPD) and lung cancer (LC) is well documented. Recent genome-wide association studies (GWAS) have identified 28 susceptibility loci for LC, 10 for COPD, 32 for smoking behavior, and 63 for pulmonary function, totaling 107 nonoverlapping loci. Given that common variants have been found to be associated with LC in genome-wide association studies, exome sequencing of these high-priority regions has ...
19 CitationsSource
#1David C. Qian (Dartmouth College)H-Index: 12
#2Jinyoung Byun (Dartmouth College)H-Index: 14
Last. Christopher I. Amos (Dartmouth College)H-Index: 132
view all 23 authors...
Results from genome-wide association studies (GWAS) have indicated that strong single-gene effects are the exception, not the rule, for most diseases. We assessed the joint effects of germline genetic variations through a pathway-based approach that considers the tissue-specific contexts of GWAS findings. From GWAS meta-analyses of lung cancer (12 160 cases/16 838 controls), breast cancer (15 748 cases/18 084 controls) and prostate cancer (14 160 cases/12 724 controls) in individuals of European...
16 CitationsSource
#1Sándor Spisák (Harvard University)H-Index: 24
#2Kate Lawrenson (SC: University of Southern California)H-Index: 28
Last. Matthew L. Freedman (Harvard University)H-Index: 71
view all 19 authors...
A pipeline incorporating genetic fine mapping, epigenome editing, and genome editing enables functional analysis of disease-associated SNPs located in non-protein-coding regions of the genome.
70 CitationsSource
#1Tracy A. O'Mara (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 23
#2Dylan M. Glubb (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 19
Last. Amanda B. Spurdle (QIMR: QIMR Berghofer Medical Research Institute)H-Index: 86
view all 70 authors...
Excessive exposure to estrogen is a well-established risk factor for endometrial cancer (EC), particularly for cancers of endometrioid histology. The physiological function of estrogen is primarily mediated by estrogen receptor alpha, encoded by ESR1. Consequently, several studies have investigated whether variation at the ESR1 locus is associated with risk of EC, with conflicting results. We performed comprehensive fine-mapping analyses of 3633 genotyped and imputed single nucleotide polymorphi...
19 CitationsSource
Cited By194
#1Maria Escala-Garcia (NKI-AVL: Netherlands Cancer Institute)H-Index: 3
#2Sander Canisius (NKI-AVL: Netherlands Cancer Institute)H-Index: 19
Last. Sabine Behrens (DKFZ: German Cancer Research Center)H-Index: 17
view all 105 authors...
Breast cancer metastasis accounts for most of the deaths from breast cancer. Identification of germline variants associated with survival in aggressive types of breast cancer may inform understanding of breast cancer progression and assist treatment. In this analysis, we studied the associations between germline variants and breast cancer survival for patients with distant metastases at primary breast cancer diagnosis. We used data from the Breast Cancer Association Consortium (BCAC) including 1...
#1Felix Grassmann (Aberd.: University of Aberdeen)H-Index: 22
#2Haomin Yang (KI: Karolinska Institutet)H-Index: 4
Last. Kamila Czene (KI: Karolinska Institutet)H-Index: 75
view all 6 authors...
Aims null In recent years, microcalcifications identified in routine mammograms were found to be associated with cardiometabolic disease in women. Here, we aimed to systematically evaluate the association of microcalcifications and other mammographic features with cardiometabolic disease risk and mortality in a large screening cohort and to understand a potential genetic contribution. null Methods and results null This study included 57 867 women from a prospective mammographic screening cohort ...
2 CitationsSource
#1Rowland W Pettit (BCM: Baylor College of Medicine)H-Index: 4
#2Jinyoung Byun (BCM: Baylor College of Medicine)H-Index: 14
Last. Christopher I. Amos (BCM: Baylor College of Medicine)H-Index: 132
view all 10 authors...
The complex polygenic nature of lung cancer is not fully characterized. Our study seeks to identify novel phenotypes associated with lung cancer using cross-trait linkage disequilibrium score regression (LDSR). We measured pairwise genetic correlation (rg) and SNP heritability (h2) between 347 traits and lung cancer risk using genome-wide association study summary statistics from the UKBB and OncoArray consortium. Further, we conducted analysis after removing genomic regions previously associate...
Despite recent notable treatment advancements, ovarian cancer survival rates remain poor, with about half of women surviving five years after diagnosis. Uncovering novel prognostic factors is critical to better understand and reduce mortality from this deadly disease. While genome-wide association studies have identified numerous loci associated with risk of epithelial ovarian cancer, the investigation of genetic factors associated with outcomes among women with ovarian cancer has been limited d...
#1Minh-Phuong Huynh-Le (UCSD: University of California, San Diego)H-Index: 10
#2Roshan Karunamuni (UCSD: University of California, San Diego)H-Index: 15
Last. Artitaya Lophatananon (University of Manchester)H-Index: 31
view all 78 authors...
Abstract null Introduction null Prostate cancer risk stratification using single-nucleotide polymorphisms (SNPs) demonstrates considerable promise in men of European, Asian, and African genetic ancestries, but there is still need for increased accuracy. We evaluated whether including additional SNPs in a prostate cancer polygenic hazard score (PHS) would improve associations with clinically significant prostate cancer in multi-ancestry datasets. null Methods null In total, 299 SNPs previously as...
1 CitationsSource
BACKGROUND Given the high heterogeneity among breast tumors, associations between common germline genetic variants and survival that may exist within specific subgroups could go undetected in an unstratified set of breast cancer patients. METHODS We performed genome-wide association analyses within 15 subgroups of breast cancer patients based on prognostic factors, including hormone receptors, tumor grade, age, and type of systemic treatment. Analyses were based on 91,686 female patients of Euro...
#1Chenyang Hou (Guangxi Medical University)H-Index: 1
#2Qingzhi Hou (Peking Union Medical College)
Last. Yuang Mao (Guangxi Medical University)
view all 10 authors...
Background null Previous observational studies have provided conflicting results on the association between serum iron status and the risk of breast cancer. Considering the relevance of this relationship to breast cancer prevention, its elucidation is warranted. null Object null We used a two-sample Mendelian randomisation (MR) study to explore the causal relationship between serum iron status and the risk of breast cancer. null Method null To select single nucleotide polymorphisms (SNPs) that c...
#1Edward K. Chang (University of Washington Medical Center)
#2Adam J. Gadzinski (University of Washington Medical Center)
Last. Yaw A. Nyame (Fred Hutchinson Cancer Research Center)H-Index: 13
view all 3 authors...
Abstract null null Objective null Partly due to the limited usefulness of prostate-specific antigen (PSA), prostate cancer screening has led to overdetection and overtreatment of clinically insignificant prostate cancer. Currently, if a patient's PSA is elevated, there is no consensus subsequent biomarker that can help providers and patients decide whether a prostate biopsy is warranted. There are numerous prostate cancer biomarkers such as PHI, 4 K, PCA3, ExoDX, SelectMDx, and MiPS that may be ...
#1Joe Dennis (University of Cambridge)H-Index: 55
#2Tyrer Jp (University of Cambridge)H-Index: 2
Last. Doug Easton (University of Cambridge)H-Index: 62
view all 122 authors...
Background: Copy number variants (CNVs) are pervasive in the human genome but potential disease associations with rare CNVs have not been comprehensively assessed in large datasets. We analysed rare CNVs in genes and non-coding regions for 86,788 breast cancer cases and 76,122 controls of European ancestry with genome-wide array data. Results: Gene burden tests detected the strongest association for deletions in BRCA1 (P= 3.7E-18). Nine other genes were associated with a p-value < 0.01 including...
#1Xizhi Luo (USC: University of South Carolina)H-Index: 2
#2Guoshuai Cai (USC: University of South Carolina)H-Index: 16
Last. Feifei Xiao (USC: University of South Carolina)H-Index: 9
view all 6 authors...
Whole-exome sequencing (WES) enables detection of Copy number variations (CNVs) with high resolution in protein-coding regions. However, variations in the intergenic or intragenic regions are excluded from studies. Fortunately, samples have been previously sequenced by other genotyping platforms, such as SNP array. Moreover, conventional single sample-based methods suffer from high false discovery rate due to prominent data noise. Therefore, methods for integrating multiple genotyping platforms ...